TORONTO, Nov. 14,
2024 /CNW/ - Neo Performance Materials Inc.
("Neo") (TSX: NEO) released its third quarter 2024 financial
results. The financial statements and management's discussion and
analysis ("MD&A") of these results can be viewed on
Neo's website at www.neomaterials.com/investors/ and on SEDAR+ at
www.sedarplus.ca.
Key Takeaways
1.
|
Increased Adjusted
EBITDA(1): Neo
reports strong financial results of $19.6 million of Adjusted
EBITDA(1) for Q3 2024 and $43.7 million of Adjusted
EBITDA(1) for the nine months ended September 30,
2024. Year-over-year Adjusted EBITDA(1) increased
for both Magnequench and Rare Metals by 23% and 30%,
respectively.
|
2.
|
Construction Nearing
Completion on European Sintered Magnet Facility: Neo's sintered
magnet facility in Europe is on track, with construction completed
on the core manufacturing building and all critical equipment
ordered. In August 2024, Neo secured a major contract with a
European automotive supplier, covering 35% of the plant's peak
capacity, with production slated for the second half of
2026.
|
3.
|
Credit Facility
Secured for Sintered Magnets Facility in Europe: In November
2024, Neo secured a $50 million credit facility from Export
Development Canada, with a five-year term to support final
construction, equipment purchases and commissioning of the
facility.
|
4.
|
Business
Simplification through Divestment: In line with Neo's strategy
to focus on high-margin, downstream business areas, Neo has
announced it has entered into agreements to divest three facilities
(two of which are in China), which are expected to generate over
$30 million in aggregate cash proceeds, and to reduce earnings
volatility and inventory.
|
5.
|
Grand Opening of
Auto Catalyst Plant: In September 2024, Neo celebrated the
opening of NAMCO, its new auto catalyst plant in Asia.
On-time and on-budget, the facility has requalified the majority of
its product portfolio and is on track to finalize the remaining
products in the coming months.
|
6.
|
Strategic Review
Progressing: Neo's financial advisors are advancing the Special
Committee-led strategic review process, and Neo continues to take
steps to optimize its business, including the divestment of
non-core assets and the improvement of operational
performance.
|
7.
|
Growth Outlook:
Neo increased its previous outlook for fiscal 2024, from $45-$50
million of Adjusted EBITDA(1), to $52-$55
million.
|
Q3 2024 Highlights
(unless otherwise noted, all financial amounts
in this news release are expressed in United States dollars)
- Neo's Q3 2024 revenue was $111.3
million, compared to Q3 2023 revenue of $136.9 million.
- Operating income for Q3 2024 was $11.2
million, compared to Q3 2023 of $7.0
million. On a year-to-date basis, 2024 operating income was
$22.9 million, compared to
$16.6 million in 2023.
- Adjusted Net Income(1) for Q3 2024 was $1.1 million, or $0.03 per share, compared to Q3 2023 Adjusted Net
Income(1) of $4.0 million
or $0.09 per share.
- Adjusted EBITDA(1) for Q3 2024 was $19.6 million, compared to Q3 2023 of
$13.2 million. On a year-to-date
basis, 2024 Adjusted EBITDA(1) was $43.7 million, compared to $34.1 million in 2023.
- On a year-to-date basis, 2024 Adjusted EBITDA(1)
margin as a percentage of revenue increased to 12.8% from 7.7%, an
improvement of 510 basis points from the prior year. Despite lower
rare earth prices negatively impacting revenue, Adjusted
EBITDA(1) was unaffected because of Neo's positioning as
a value-added downstream business with much of the commodity inputs
tied to pass-through agreements.
- Neo had $64.9 million in cash and
$45.1 million in gross debt on its
balance sheet as of September 30,
2024. Neo invested $52.2
million in capital expenditures for the nine months ended
September 30, 2024, including
sustaining capital expenditures of $3.1
million.
- Neo distributed $9.3 million in
dividends to Neo's shareholders and repurchased for cancellation
$2.3 million of common shares in the
first nine months of the year.
- A quarterly dividend of Cdn$0.10
per common share was declared on November
13, 2024, for shareholders of record on December 17, 2024, with a payment date of
December 27, 2024.
"Neo is pleased to report another solid quarter, with Adjusted
EBITDA(1) up approximately 50% year-over-year to
$19.6 million and 30% year-to-date.
This performance, driven by growth in our Magnequench and Rare
Metals business units, reaffirms our business strategy and
approach," said Rahim Suleman, Neo's
President and Chief Executive Officer. "Our focus on high-margin,
downstream opportunities and strategic simplification of the
business is generating tangible results for shareholders."
"Recent asset dispositions anticipated to generate over
$30 million in cash will streamline
our portfolio and are anticipated to reduce our business
volatility," continued Mr. Suleman. "With our new NAMCO
facility now operational and our European magnet project advancing,
we are well-positioned to gain market share in higher-margin
downstream businesses. Our progress over the past year sets a
strong foundation for continued value creation and sustainable
growth."
SOLID FINANCIAL PERFORMANCE DESPITE INDUSTRY
HEADWINDS
- In Q3 2024, Magnequench achieved its highest quarterly volume
of the year, driven by strong traction motor sales and spot demand
in bonded powder.
- Magnequench is well-positioned in the traction motor market,
offering the only heavy rare earth free magnet for traction motor
platforms. Neo's future growth looks promising with the addition of
a new sintered magnet facility currently under construction in
Europe.
- Neo's Chemical & Oxides ("C&O") business unit
experienced weaker performance, largely driven by lower rare earth
prices that impacted the rare earth separation business. To address
this and reduce volatility, Neo has strategically shifted focus to
Europe by entering into agreements
to divest its two rare earth separation facilities in China.
- This move aligns with Neo's broader strategy to focus on
higher-margin, downstream applications. C&O's asset base,
post-divestiture, will be comprised of its European separation
business and the newly built NAMCO facility for global auto
catalyst customers, while still maintaining specialty heavy rare
earth sales to international customers.
- Neo's Rare Metals business unit saw impressive growth in Q3
2024, which significantly contributed to Neo's overall performance.
- A major factor in this strong showing was exceptional pricing
for hafnium, which bolstered revenue and Adjusted
EBITDA(1) over the past several quarters. Neo expects
hafnium pricing to normalize gradually but remains well-positioned
to satisfy global demands for critical metals, including hafnium,
niobium, gallium and tantalum.
SINTERED MAGNET FACILITY CONSTRUCTION ON-TIME AND
ON-BUDGET
- Neo is expanding its European footprint with the construction
of a sintered magnet facility in Estonia. This project is set to drive Neo's
growth by positioning the Company as a leading magnet supplier in
Europe while supporting
sustainable and secure local supply chains for critical materials.
The project remains on-schedule and on-budget.
- The plant is strategically located near Neo's rare earth
separation facility and is designed to support demand for clean
energy technologies, including electric vehicle traction motors and
wind turbines.
- Neo has taken a phased investment approach, with Phase 1
providing an initial capacity of 2,000 tonnes per year, with the
potential to expand to 5,000 tonnes per year.
- Neo estimates that Phase 1 of the new sintered magnet facility
in Europe will cost $75.0 million before the European Union grant.
Neo has spent $32.7 million in the
first nine months of 2024 and $41.7
million in capital expenditures since the project
began.
- In August 2024, Neo received its
first major contract for this facility from a Tier 1 European
automotive supplier, with production expected to start in the
second half of 2026.
- In November 2024, Neo secured a
$50.0 million credit facility from
Export Development Canada ("EDC"), with a five-year term to
support final construction, equipment purchases and commissioning
of the facility.
IMPROVED OPERATIONAL PERFORMANCE
- Operational improvements in Neo's Magnequench operating
facilities in Asia, including a
20% reduction in conversion costs, have also strengthened margins,
enhancing the business' financial performance.
- The NAMCO facility reached significant operational milestones
in 2024, with its official grand opening in September.
- Equipped with advanced infrastructure, transportation,
wastewater treatment systems, and automated manufacturing layouts,
NAMCO is strategically positioned to support more stringent
emission standards across hybrid and internal combustion vehicle
platforms.
- The facility has already requalified the majority of its
product portfolio and remains on track to requalify the pending
products over the coming months.
- The NAMCO capital project has also been delivered below budget,
with estimated total capital expenditures of approximately
$70.0 million — $5.0 million below budget.
- Neo has invested $47.8 million in
the NAMCO project to date, including $14.2
million in 2024, with remaining expenditures expected by
early 2025.
- For this project, Neo has a $75.0
million credit facility from EDC, of which $50.0 million has been drawn to date.
CONTINUED BUSINESS SIMPLIFICATION
- In August 2024, Neo announced
that it has entered into agreements to sell an 86% equity interest
in its Jiangyin-based rare earth separation facility (JAMR) and a
full divestment of its Zibo facility (ZAMR).
- These divestitures target a streamlined operational focus and
are anticipated to return cash to Neo, reduce working capital
needs, and minimize earnings volatility driven by rare earth price
fluctuations.
- The JAMR sale includes a five-year distribution agreement,
allowing Neo to maintain access to key high-purity products for its
downstream customers while freeing resources from the highly
regulated and competitive rare earth separation business in
China.
- In August 2024, Neo announced
that it has entered into an agreement to sell its 80% equity stake
in its gallium trichloride production facility located in
Quapaw, Oklahoma.
- The sale aligns with Neo's strategy to refine its global
operating footprint by focusing on high-value downstream
applications.
- The transaction is expected to include a seven-year supply
agreement with the buyer for ongoing gallium recycling support from
its Peterborough, Ontario
facility.
- Neo anticipates that each of these translations will close in
Q4 2024.
STRATEGIC REVIEW
- Neo continues to progress its previously announced Special
Committee-led strategic review process, which includes the
consideration of strategic alternatives and opportunities to
maximize shareholder value. The Strategic Committee retained
Barclays Capital Inc. and Paradigm Capital Inc. as independent
financial advisors who are advancing the strategic review process.
Neo's financial advisors are advancing the strategic review
process, and Neo continues to take steps to optimize its business,
including the divestment of non-core assets, and the improvement of
operational performance, significant customer wins, and progress of
major capital projects, both on-time and on-budget. Through these
initiatives and Neo's continuing focus on value-maximizing
alternatives, Neo is advancing the strategic review process.
- There can be no assurance that the strategic review process
will result in any transaction or other alternative, nor any
assurance as to its outcome or timing. There is no timetable for
completion of this process.
2024 OUTLOOK
- Neo previously communicated a fiscal year 2024 Adjusted
EBITDA(I) outlook of $45-$50 million.
With the outperformance in Rare Metals during the third quarter of
2024, Neo raises its fiscal year 2024 Adjusted EBITDA(I)
outlook to a range of $52-$55 million, an
approximate 40% to 48% increase over the prior year.
- For fiscal year 2025, Neo previously communicated a
double-digit percentage Adjusted EBITDA(I) growth
compared to the original guidance for fiscal year 2024.
Notwithstanding the three divestitures anticipated to close by the
end of 2024, Neo anticipates fiscal year 2025 Adjusted
EBITDA(I) outlook in the range of $53-$58
million.
CONFERENCE CALL ON THURSDAY, NOVEMBER
14, 2024 AT 10 AM
EASTERN
Management will host a teleconference call on Thursday, November 14, 2024 at 10:00 a.m. (Eastern Time) to discuss the third
quarter 2024 results. Interested parties may access the
teleconference by calling (437) 900-0527 (local) or (888) 510-2154
(toll free long distance) or by visiting
https://app.webinar.net/v32pRWbDxgQ. A recording of the
teleconference may be accessed by calling (289) 819-1450 (local) or
(888) 660-6345 (toll free long distance), and entering pass code
40961# until December 14, 2024.
NON-IFRS MEASURES
This news release refers to certain non-IFRS financial measures
and ratios such as "Adjusted Net Income", "EBITDA", "Adjusted
EBITDA", and "Adjusted EBITDA Margin". These measures and ratios
are not recognized measures under IFRS, do not have a
standardized meaning prescribed by IFRS, and may not be comparable
to similar measures presented by other companies. Rather, these
measures and ratios are provided as additional information to
complement IFRS financial measures by providing further
understanding of Neo's results of operations from management's
perspective. Neo's definitions of non-IFRS measures used in this
news release may not be the same as the definitions for such
measures used by other companies in their reporting. Non-IFRS
measures and ratios have limitations as analytical tools and should
not be considered in isolation nor as a substitute for analysis of
Neo's financial information reported under IFRS. Neo uses
non-IFRS financial measures and ratios to provide investors with
supplemental measures of its base-line operating performance and to
eliminate items that have less bearing on operating performance or
operating conditions and thus highlight trends in its core business
that may not otherwise be apparent when relying solely on IFRS
financial measures. Neo believes that securities analysts,
investors and other interested parties frequently use non-IFRS
financial measures and ratios in the evaluation of issuers.
Neo's management also uses non-IFRS financial measures to
facilitate operating performance comparisons from period to period.
For definitions of how Neo defines such financial measures and
ratios, please see the "Non-IFRS Financial Measures" section of
Neo's management's discussion and analysis filing for the three and
nine months ended September 30, 2024,
available on Neo's web site at www.neomaterials.com and on SEDAR+
at www.sedarplus.ca.
HIGHLIGHTS OF THIRD
QUARTER 2024 CONSOLIDATED PERFORMANCE
|
|
|
|
|
|
|
|
|
|
($000s, except
volume and per share information)
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
Volume
|
|
|
|
|
|
|
|
|
|
Magnequench
|
|
1,366
|
|
1,389
|
|
3,769
|
|
3,413
|
|
C&O
|
|
1,605
|
|
2,137
|
|
5,287
|
|
6,174
|
|
Rare Metals
|
|
81
|
|
79
|
|
256
|
|
259
|
|
Corporate /
Eliminations
|
|
(16)
|
|
(20)
|
|
(56)
|
|
—
|
|
Total
Volume
|
|
3,036
|
|
3,585
|
|
9,256
|
|
9,846
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
|
|
|
|
|
|
|
|
Magnequench
|
|
$
45,573
|
|
$
54,414
|
|
$
133,149
|
|
$
158,908
|
|
C&O
|
|
27,920
|
|
57,812
|
|
102,911
|
|
180,377
|
|
Rare Metals
|
|
38,578
|
|
25,976
|
|
107,765
|
|
104,877
|
|
Corporate /
Eliminations
|
|
(790)
|
|
(1,285)
|
|
(2,900)
|
|
(1,285)
|
|
Consolidated
Revenue
|
|
$
111,281
|
|
$
136,917
|
|
$
340,925
|
|
$
442,877
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income
(Loss)
|
|
|
|
|
|
|
|
|
|
Magnequench
|
|
$
2,465
|
|
$
2,911
|
|
$
8,106
|
|
$
4,943
|
|
C&O
|
|
(975)
|
|
6,068
|
|
(2,881)
|
|
1,466
|
|
Rare Metals
|
|
15,852
|
|
2,749
|
|
33,225
|
|
25,267
|
|
Corporate /
Eliminations
|
|
(6,166)
|
|
(4,769)
|
|
(15,502)
|
|
(15,039)
|
|
Consolidated
Operating Income
|
|
$
11,176
|
|
$
6,959
|
|
$
22,948
|
|
$
16,637
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Earnings
Before Interest, Taxes, Depreciation and Amortization ("Adjusted
EBITDA") (1)
|
Magnequench
|
|
$
6,424
|
|
$
6,042
|
|
$
18,704
|
|
$
15,199
|
|
C&O
|
|
1,301
|
|
7,737
|
|
3,572
|
|
6,088
|
|
Rare Metals
|
|
16,355
|
|
3,293
|
|
34,379
|
|
26,407
|
|
Corporate /
Eliminations
|
|
(4,525)
|
|
(3,912)
|
|
(12,948)
|
|
(13,572)
|
|
Consolidated
Adjusted EBITDA(1)
|
|
$
19,555
|
|
$
13,160
|
|
$
43,707
|
|
$
34,122
|
|
|
|
|
|
|
|
|
|
|
|
Net (Loss)
Income
|
|
$
(2,711)
|
|
$
3,109
|
|
$
(979)
|
|
$
(7,262)
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (Loss) per
share attributable to equity holders of Neo
|
|
Basic
|
|
$
(0.06)
|
|
$
0.07
|
|
$
(0.02)
|
|
$
(0.16)
|
|
Diluted
|
|
$
(0.06)
|
|
$
0.07
|
|
$
(0.02)
|
|
$
(0.16)
|
|
|
|
|
|
|
|
|
|
|
|
Cash spent on property,
plant and equipment and intangible assets
|
|
$
25,527
|
|
$
7,752
|
|
$
52,183
|
|
$
17,404
|
|
Cash taxes
paid
|
|
$
5,529
|
|
$
3,288
|
|
$
18,832
|
|
$
11,321
|
|
Dividends paid to
shareholders
|
|
$
3,057
|
|
$
3,339
|
|
$
9,268
|
|
$
10,061
|
|
Dividends paid to
non-controlling interest
|
|
$
7,967
|
|
$
—
|
|
$
7,967
|
|
$
—
|
|
Repurchase of common
shares under Normal Course Issuer Bid
|
|
$
—
|
|
$
15,482
|
|
$
2,250
|
|
$
16,684
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September
30
|
December
31
|
|
|
|
|
|
|
|
2024
|
|
2023
|
|
Cash and cash
equivalents
|
|
|
|
|
$
64,944
|
|
$
86,895
|
|
Restricted
cash
|
|
|
|
|
$
—
|
|
$
3,357
|
|
Current & long-term
debt
|
|
|
|
|
$
45,070
|
|
$
25,331
|
|
____________________________
|
(1)Neo
reports non-IFRS measures such as "Adjusted Net Income", "Adjusted
Earnings per Share", "Adjusted EBITDA", "Adjusted EBITDA Margin"
and "EBITDA". Please see information on this and other non-IFRS
measures in the "Non-IFRS Measures" section of this news release
and in the MD&A, available on Neo's website at
www.neomaterials.com and on
SEDAR+ at
www.sedarplus.ca
|
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
($000s)
|
|
September 30,
2024
|
|
December 31,
2023
|
ASSETS
|
|
|
|
|
Current
|
|
|
|
|
Cash and cash
equivalents
|
|
$
64,944
|
|
$
86,895
|
Restricted
cash
|
|
—
|
|
3,357
|
Accounts
receivable
|
|
67,777
|
|
67,643
|
Inventories
|
|
138,824
|
|
197,453
|
Income taxes
receivable
|
|
2,405
|
|
744
|
Assets held for
sale
|
|
47,809
|
|
—
|
Other current
assets
|
|
32,933
|
|
22,542
|
Total current
assets
|
|
354,692
|
|
378,634
|
Property, plant and
equipment
|
|
164,026
|
|
118,918
|
Intangible
assets
|
|
35,427
|
|
38,511
|
Goodwill
|
|
65,735
|
|
65,160
|
Investments
|
|
15,403
|
|
17,955
|
Deferred tax
assets
|
|
3,120
|
|
6,760
|
Other non-current
assets
|
|
1,062
|
|
1,066
|
Total non-current
assets
|
|
284,773
|
|
248,370
|
Total
assets
|
|
$
639,465
|
|
$
627,004
|
|
|
|
|
|
LIABILITIES AND
EQUITY
|
|
|
|
|
Current
|
|
|
|
|
Accounts payable and
other accrued charges
|
|
$
63,134
|
|
$
71,984
|
Income taxes
payable
|
|
6,311
|
|
9,207
|
Provisions
|
|
558
|
|
823
|
Lease
obligations
|
|
1,394
|
|
1,664
|
Derivative
liability
|
|
41,905
|
|
36,294
|
Current portion of
long-term debt
|
|
5,181
|
|
2,230
|
Liabilities directly
associated with the assets held for sale
|
|
17,355
|
|
—
|
Other current
liabilities
|
|
921
|
|
692
|
Total current
liabilities
|
|
136,759
|
|
122,894
|
Long-term
debt
|
|
39,889
|
|
23,101
|
Employee
benefits
|
|
124
|
|
108
|
Derivative
liability
|
|
1,402
|
|
1,082
|
Provisions
|
|
19,241
|
|
26,197
|
Deferred tax
liabilities
|
|
11,254
|
|
14,294
|
Lease
obligations
|
|
3,704
|
|
2,425
|
Other non-current
liabilities
|
|
1,335
|
|
1,592
|
Total non-current
liabilities
|
|
76,949
|
|
68,799
|
Total
liabilities
|
|
213,708
|
|
191,693
|
Non-controlling
interest
|
|
3,238
|
|
3,164
|
Equity attributable to
equity holders of Neo Performance Materials Inc.
|
|
422,519
|
|
432,147
|
Total
equity
|
|
425,757
|
|
435,311
|
Total liabilities
and equity
|
|
$
639,465
|
|
$
627,004
|
See accompanying
notes to this table in Neo's Interim Condensed Consolidated
Financial Statements for the three and nine months ended September
30, 2024, available on Neo's website at www.neomaterials.com
and on SEDAR+ at www.sedarplus.ca.
|
CONSOLIDATED RESULTS OF OPERATIONS
Comparison of the three and nine months ended September 30, 2024 to the three and nine months
ended September 30, 2023:
($000s)
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Revenue
|
|
$
111,281
|
|
$
136,917
|
|
$
340,925
|
|
$
442,877
|
Cost of
sales
|
|
|
|
|
|
|
|
|
Cost excluding
depreciation and amortization
|
|
75,851
|
|
106,255
|
|
248,849
|
|
355,465
|
Depreciation and
amortization
|
|
2,107
|
|
2,674
|
|
6,041
|
|
7,210
|
Gross
profit
|
|
33,323
|
|
27,988
|
|
86,035
|
|
80,202
|
Expenses
|
|
|
|
|
|
|
|
|
Selling, general and
administrative
|
|
15,707
|
|
13,688
|
|
44,954
|
|
44,670
|
Share-based
compensation
|
|
909
|
|
1,024
|
|
2,289
|
|
1,792
|
Depreciation and
amortization
|
|
1,791
|
|
1,794
|
|
5,395
|
|
5,374
|
Research and
development
|
|
3,474
|
|
4,523
|
|
9,976
|
|
11,729
|
Impairment of
assets
|
|
266
|
|
—
|
|
473
|
|
—
|
|
|
22,147
|
|
21,029
|
|
63,087
|
|
63,565
|
Operating
income
|
|
11,176
|
|
6,959
|
|
22,948
|
|
16,637
|
Other (expense)
income
|
|
(696)
|
|
1,011
|
|
2,897
|
|
362
|
Finance (costs)
income, net
|
|
(10,695)
|
|
648
|
|
(13,607)
|
|
(7,449)
|
Foreign exchange gain
(loss)
|
|
1,235
|
|
(190)
|
|
(31)
|
|
(1,432)
|
Income from
operations before income
taxes and equity loss of associates
|
|
1,020
|
|
8,428
|
|
12,207
|
|
8,118
|
Income tax
expense
|
|
(2,991)
|
|
(4,124)
|
|
(10,374)
|
|
(11,722)
|
(Loss) income from
operations before
equity loss of associates
|
|
(1,971)
|
|
4,304
|
|
1,833
|
|
(3,604)
|
Equity loss of
associates (net of income tax)
|
|
(740)
|
|
(1,195)
|
|
(2,812)
|
|
(3,658)
|
Net (loss)
income
|
|
$
(2,711)
|
|
$
3,109
|
|
$
(979)
|
|
$
(7,262)
|
Attributable
to:
|
|
|
|
|
|
|
|
|
Equity holders of Neo
Performance Materials Inc.
|
|
$
(2,627)
|
|
$
3,069
|
|
$
(895)
|
|
$
(7,075)
|
Non-controlling
interest
|
|
(84)
|
|
40
|
|
(84)
|
|
(187)
|
|
|
$
(2,711)
|
|
$
3,109
|
|
$
(979)
|
|
$
(7,262)
|
(Loss) earnings per
share attributable to equity holders
of Neo Performance Materials Inc.:
|
|
|
|
|
|
|
Basic
|
|
$
(0.06)
|
|
$
0.07
|
|
$
(0.02)
|
|
$
(0.16)
|
Diluted
|
|
$
(0.06)
|
|
$
0.07
|
|
$
(0.02)
|
|
$
(0.16)
|
See Management's
Discussion and Analysis for the three and nine months ended
September 30, 2024, available on Neo's website
at www.neomaterials.com and on SEDAR+ at
www.sedarplus.ca
|
RECONCILIATIONS OF NET (LOSS) INCOME TO EBITDA, ADJUSTED
EBITDA AND FREE CASH FLOW
($000s)
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net (loss)
income
|
|
$
(2,711)
|
|
$
3,109
|
|
$
(979)
|
|
$
(7,262)
|
Add back
(deduct):
|
|
|
|
|
|
|
|
|
Finance costs
(income), net
|
|
10,695
|
|
(648)
|
|
13,607
|
|
7,449
|
Income tax
expense
|
|
2,991
|
|
4,124
|
|
10,374
|
|
11,722
|
Depreciation and
amortization included in cost of sales
|
|
2,107
|
|
2,674
|
|
6,041
|
|
7,210
|
Depreciation and
amortization included in operating expenses
|
|
1,791
|
|
1,794
|
|
5,395
|
|
5,374
|
EBITDA
|
|
14,873
|
|
11,053
|
|
34,438
|
|
24,493
|
Adjustments to
EBITDA:
|
|
|
|
|
|
|
|
|
Other expense (income)
(1)
|
|
696
|
|
(1,011)
|
|
(2,897)
|
|
(362)
|
Foreign exchange
(gain) loss (2)
|
|
(1,235)
|
|
190
|
|
31
|
|
1,432
|
Equity loss of
associates
|
|
740
|
|
1,195
|
|
2,812
|
|
3,658
|
Share-based
compensation (3)
|
|
909
|
|
1,024
|
|
2,289
|
|
1,792
|
Fair value adjustments
to inventory acquired
|
|
—
|
|
423
|
|
—
|
|
995
|
Project startup &
transition costs (4)
|
|
2,228
|
|
286
|
|
5,483
|
|
913
|
Transaction and other
costs (5)
|
|
1,078
|
|
—
|
|
1,078
|
|
1,201
|
Impairment of assets
(6)
|
|
266
|
|
—
|
|
473
|
|
—
|
Adjusted
EBITDA(I)
|
|
$ 19,555
|
|
$ 13,160
|
|
$
43,707
|
|
$
34,122
|
Adjusted EBITDA
Margins (7)
|
|
17.6 %
|
|
9.6 %
|
|
12.8 %
|
|
7.7 %
|
Less:
|
|
|
|
|
|
|
|
|
Capital expenditures
(8)
|
|
$ 21,339
|
|
$
7,793
|
|
$
57,387
|
|
$
19,629
|
Free Cash Flow
(7)
|
|
$
(1,784)
|
|
$
5,367
|
|
$
(13,680)
|
|
$
14,493
|
Free Cash Flow
Conversion (9)
|
|
(9.1 %)
|
|
40.8 %
|
|
(31.3 %)
|
|
42.5 %
|
Notes:
|
(1)
|
Represents other
expense (income) resulting from non-operational related activities,
including provisions for damages for outstanding legal claims
related to historic volumes. In addition, other income for
the nine months ended September 30, 2024 includes the reversal of a
special reserve to cover for potential liabilities related to
employee safety incidents or workplace accidents at the ZAMR
facility. This reserve was released when Neo shut down this
operation. These items are not indicative of Neo's ongoing
activities.
|
(2)
|
Represents unrealized
and realized foreign exchange losses that include non-cash
adjustments in translating foreign denominated monetary assets and
liabilities.
|
(3)
|
Represents share-based
compensation expense in respect of the long-term incentive plans
(the "LTIP") which was adopted on May 9, 2018 as well as the
Omnibus long-term incentive plan (the "Omnibus LTIP"), which
was originally approved by shareholders on June 29, 2021 and
amended and approved by shareholders on June 19, 2024. No
further grants were made under the LTIP once the Omnibus LTIP was
adopted. There are no RSUs and PSUs outstanding under the
LTIP and no further grants will be made under the LTIP.
|
(4)
|
Represents start-up
costs (primarily pre-operational staffing costs) at Neo's new
European sintered magnet facility, as well as transition cost
during qualification and start-up of the NAMCO facility and winding
down of the ZAMR facility. Neo has removed these charges to
provide comparability with historic periods.
|
(5)
|
Represents costs
related to a comprehensive strategic review of Neo's current
operation strategy and capital structure. These costs
primarily consist of professional fees for legal advisors, bankers,
and other specialists engaged in evaluating and advising on
strategic alternatives aimed at enhancing shareholder value.
Neo has removed these charges to provide comparability with
historic periods.
|
(6)
|
For the three months
ended September 30, 2024, an impairment charge of $0.3 million was
recorded as a result of the classification of the JAMR and ZAMR
disposal group as held for sale. For the nine months ended
September 30, 2024, an impairment charge of $0.6 million was
recorded as a result of the shutdown of the light rare earth
separation business in ZAMR; an impairment charge of $0.3 million
as a result of the classification of the JAMR and ZAMR disposal
group as held for sale; and a reversal of an asset impairment of
$0.4 million previously recorded in Neo's Rare Metals hafnium
business.
|
(7)
|
Neo reports non-IFRS
measures such as "Adjusted Net Income", "Adjusted Earnings per
Share", "Adjusted EBITDA", "Adjusted EBITDA Margin", "Free Cash
Flow" and "Free Cash Flow Conversion". Please see information on
this and other non-IFRS measures in the "Non-IFRS Measures" section
of this news release and in the MD&A, available on Neo's
website www.neomaterials.com and on SEDAR+ at
www.sedarplus.ca.
|
(8)
|
Includes cash and
non-cash capital expenditures of $21.2 million and $54.1 million,
respectively, and right-of-use assets of $0.1 million and $3.3
million, respectively, for the three and nine months ended
September 30, 2024. For the three and nine months ended
September 30, 2023, the amount was comprised of cash and non-cash
capital expenditures of $7.8 million and $17.4 million,
respectively, and right-of-use assets of $nil million and $2.2
million, respectively.
|
(9)
|
Calculated as Free Cash
Flow divided by Adjusted EBITDA(I).
|
RECONCILIATIONS OF NET (LOSS) INCOME TO ADJUSTED NET INCOME
(LOSS)
($000s)
|
|
Three Months
Ended
September 30,
|
|
Nine Months
Ended
September 30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net (loss)
income
|
|
$
(2,711)
|
|
$
3,109
|
|
$
(979)
|
|
$
(7,262)
|
Adjustments to net
(loss) income:
|
|
|
|
|
|
|
|
|
Foreign exchange
(gain) loss (1)
|
|
(1,235)
|
|
190
|
|
31
|
|
1,432
|
Impairment of assets
(2)
|
|
266
|
|
—
|
|
473
|
|
—
|
Share-based
compensation (3)
|
|
909
|
|
1,024
|
|
2,289
|
|
1,792
|
Project start-up &
transition cost (4)
|
|
2,228
|
|
286
|
|
5,483
|
|
913
|
Other items included
in other expense (income) (5)
|
|
891
|
|
(897)
|
|
(1,999)
|
|
(278)
|
Fair value adjustments
to inventory acquired
|
|
—
|
|
423
|
|
—
|
|
995
|
Transaction and other
costs (6)
|
|
1,078
|
|
—
|
|
1,078
|
|
1,201
|
Tax impact of the
above items
|
|
(287)
|
|
(122)
|
|
407
|
|
(669)
|
Adjusted net income
(loss)
|
|
$
1,139
|
|
$
4,013
|
|
$
6,783
|
|
$
(1,876)
|
|
|
|
|
|
|
|
|
|
Attributable
to:
|
|
|
|
|
|
|
|
|
Equity holders of
Neo
|
|
$
1,223
|
|
$
3,973
|
|
$
6,867
|
|
$
(1,689)
|
Non-controlling
interest
|
|
$
(84)
|
|
$
40
|
|
$
(84)
|
|
$
(187)
|
|
|
|
|
|
|
|
|
|
Weighted average
number of common shares outstanding:
|
Basic
|
|
41,751,560
|
|
44,517,503
|
|
41,778,174
|
|
44,967,960
|
Diluted
|
|
42,465,913
|
|
45,019,400
|
|
42,459,386
|
|
44,967,960
|
Adjusted income
(loss) per share (7)
attributable to equity holders of Neo:
|
Basic
|
|
$
0.03
|
|
$
0.09
|
|
$
0.16
|
|
$
(0.04)
|
Diluted
|
|
$
0.03
|
|
$
0.09
|
|
$
0.16
|
|
$
(0.04)
|
Notes:
|
(1)
|
Represents unrealized
and realized foreign exchange losses that include non-cash
adjustments in translating foreign denominated monetary assets and
liabilities.
|
(2)
|
For the three months
ended September 30, 2024, an impairment charge of $0.3 million was
recorded as a result of the classification of the JAMR and ZAMR
disposal group as held for sale. For the nine months ended
September 30, 2024, an impairment charge of $0.6 million was
recorded as a result of the shutdown of the light rare earth
separation business in ZAMR; an impairment charge of $0.3 million
as a result of the classification of the JAMR and ZAMR disposal
group as held for sale; and a reversal of an asset impairment of
$0.4 million previously recorded in Neo's Rare Metals hafnium
business.
|
(3)
|
Represents share-based
compensation expense in respect of the LTIP which was adopted on
May 9, 2018 as well as the Omnibus LTIP, which was originally
approved by shareholders on June 29, 2021 and amended and approved
by shareholders on June 19, 2024. No further grants were made
under the LTIP once the Omnibus LTIP was adopted. There are
no RSUs and PSUs outstanding under the LTIP and no further grants
will be made under the LTIP.
|
(4)
|
Represents start-up
costs (primarily pre-operational staffing costs) at Neo's new
European sintered magnet facility, as well as transition cost
during qualification and start-up of the NAMCO facility and winding
down of the ZAMR facility. Neo has removed these charges to
provide comparability with historic periods.
|
(5)
|
Represents other
expense (income) resulting from non-operational related activities,
including provisions for damages for outstanding legal claims
related to historic volumes. In addition, other income for
the nine months ended September 30, 2023 includes the reversal of a
special reserve to cover for potential liabilities related to
employee safety incidents or workplace accidents at the ZAMR
facility. This reserve was released when Neo shut down this
operation. These items are not indicative of Neo's
ongoing activities.
|
(6)
|
Represents costs
related to a comprehensive strategic review of Neo's current
operation strategy and capital structure. These costs
primarily consist of professional fees for legal advisors, bankers,
and other specialists engaged in evaluating and advising on
strategic alternatives aimed at enhancing shareholder value.
Neo has removed these charges to provide comparability with
historic periods.
|
(7)
|
Neo reports non-IFRS
measures such as "Adjusted Net Income", "Adjusted Earnings per
Share", "Adjusted EBITDA", "Adjusted EBITDA Margin", "Free Cash
Flow" and "Free Cash Flow Conversion". Please see information on
this and other non-IFRS measures in the "Non-IFRS Measures" section
of this news release and in the MD&A, available on Neo's
website www.neomaterials.com and on SEDAR+ at
www.sedarplus.ca.
|
About Neo Performance Materials
Neo manufactures the building blocks of many modern technologies
that enhance efficiency and sustainability. Neo's advanced
industrial materials - magnetic powders and magnets, specialty
chemicals, metals, and alloys - are critical to the performance of
many everyday products and emerging technologies. Neo's products
help to deliver the technologies of tomorrow to consumers today.
Neo's business is organized into three segments: Magnequench,
Chemicals & Oxides, and Rare Metals. Neo is headquartered in
Toronto, Ontario, Canada; with
corporate offices in Greenwood Village,
Colorado, United States;
Singapore; and Beijing, China. Neo has a global platform that
includes 9 manufacturing facilities located in China, the United
States, Germany,
Canada, Estonia, Thailand and the United Kingdom, as well as one dedicated
research and development centre in Singapore. For more information, please
visit www.neomaterials.com.
Cautionary Statements Regarding Forward Looking
Statements
This news release contains "forward-looking information" within
the meaning of applicable securities laws in Canada. Forward-looking information may relate
to future events or the future performance of Neo. All statements
in this release, other than statements of historical facts, with
respect to Neo's objectives and goals, as well as statements with
respect to its beliefs, plans, objectives, expectations,
anticipations, estimates, and intentions, are forward-looking
information. Specific forward-looking statements in this discussion
include, but are not limited to, the following: expectations
regarding certain of Neo's future results and information,
including, among other things, revenue, expenses, sales growth,
capital expenditures, and operations; statements with respect to
current and future market trends that may directly or indirectly
impact sales and revenue of Neo, including but not limited to the
price of rare earth elements; expected use of cash balances;
continuation of prudent management of working capital; source of
funds for ongoing business requirements and capital investments;
expectations regarding sufficiency of the allowance for
uncollectible accounts and inventory provisions; analysis regarding
sensitivity of the business to changes in exchange rates; impact of
recently adopted accounting pronouncements; risk factors relating
to intellectual property protection and intellectual property
litigation; risk factors relating to national or international
economies, geopolitical risk and other risks present in the
jurisdictions in which Neo, its customers, its suppliers, and/or
its logistics partners operate, and; expectations concerning any
remediation efforts to Neo's design of its internal controls over
financial reporting and disclosure controls and procedures. Often,
but not always, forward-looking information can be identified by
the use of words such as "plans", "expects", "is expected",
"budget", "scheduled", "estimates", "continues", "forecasts",
"projects", "predicts", "intends", "anticipates" or "believes", or
variations of, or the negatives of, such words and phrases, or
state that certain actions, events or results "may", "could",
"would", "should", "might" or "will" be taken, occur or be
achieved. This information involves known and unknown risks,
uncertainties and other factors that may cause actual results or
events to differ materially from those anticipated in such
forward-looking information. Neo believes the expectations
reflected in such forward-looking information are reasonable, but
no assurance can be given that these expectations will prove to be
correct and such forward-looking information included in this news
release should not be unduly relied upon. For more information on
Neo, investors should review Neo's continuous disclosure filings
that are available under Neo's profile at www.sedarplus.ca.
SOURCE Neo Performance Materials, Inc.